Article: labcompare – Advancing biomarker technology to increase early-stage cancer diagnostics

With the UK’s growing and ageing population, cancer diagnoses are expected to exceed half a million annually by 2038-2040¹. Early detection is crucial to improving patient outcomes and increasing survival rate. Valley Diagnostics is developing rapid, accurate and cost-effective lateral flow tests to make early diagnosis of cancer more reliable. In this article, Dave Taylor, CEO of Valley Diagnostics, shares insights into the challenges of cancer testing, the potential of biomarker testing for cancer diagnosis and how lateral flow tests could reshape the future of cancer diagnostics. Read the article in full on labcompare here.

1. Haroon Siddique. “More than 500,000 People in UK Will Be Diagnosed with Cancer Each Year by 2040.” The Guardian, February 3, 2023. https://www.theguardian.com/society/2023/feb/03/more-than-500000-people-in-uk-will-be-diagnosed-with-cancer-each-year-by-2040.